A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart ...

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

Iron deficiency—when there's too little iron in the blood—may affect a quarter of the world's population, and in particular, women of reproductive age. Symptoms can include fatigue and shortness of ...

The 'heart' of the Fanconi anemia core complex, composed of FANCB-FANCL-FAAP100 (now FANCX) proteins, allows the rest of the ...

Welcome to the OraSure Technologies, Inc. 2025 first-quarter earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

The list of musicians currently fighting cancer has grown far too long. Here are 14 popular artists who are battling the ...

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report ... Grail cutting-edge cancer blood test has stirred investor ...

The global precision medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of 11.1%, ...

The National Comprehensive Cancer Network (NCCN) policy summit, “Primary Care and Oncology Collaboration to Improve Patient ...

First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $43.6 million and contract revenues from collaborations of $9.8 ...

Every year on May 8, the world observes World Ovarian Cancer Day to spread awareness about ovarian cancer, the second most ...

First quarter 2025 net loss was approximately $10.7 million, or $0.36 per common share, compared to approximately $6.6 million, or $0.27 per common share, in the three months ended March 31, 2024. As ...